U.S. stocking partner for NeuroDyne1 fl oz dropper bottle · about 30 daysFree U.S. shipping on 3 or 6 bottles60-day money-back window
Order now

Ingredient evidence

Does Ginkgo Improve Memory? The GEM Trial Result and Neuro Dyne

Quick answer

Ginkgo did not protect memory in the largest trial ever run on it. In the GEM trial, 3,069 adults aged 75 and up took 120 mg twice daily or placebo for a median 6.1 years. Of those on ginkgo, 17.9% developed dementia, against 16.1% on placebo (DeKosky et al., 2008) (GEM trial results, 2008). NeuroDyne names ginkgo but publishes no amount.

Written by the NeuroDyne editorial teamUpdated · 9 min read

Two amber NeuroDyne dropper bottles with gold collars and navy labels reading Cognitive Support Formula
NeuroDyne's front label claims it enhances memory recall. Ginkgo is one of its three named herbs; the amount is not printed in any image we have.

Short answer

Does ginkgo biloba improve memory?

The best evidence says no, at least not enough to prevent decline. The GEM trial is the largest test of ginkgo and memory, and ginkgo did not beat placebo (DeKosky et al., 2008).

The National Center for Complementary and Integrative Health reaches the same view. In large studies, ginkgo did not lower the risk of dementia (NCCIH, Ginkgo), and there is no conclusive evidence it slows cognitive decline (NCCIH, 7 things).

Ginkgo is still sold widely for memory. That is legal for supplements, because FDA does not review them for effectiveness before they go on sale (FDA, Using supplements).

The trial

What was the GEM trial?

GEM stands for Ginkgo Evaluation of Memory. It was a placebo-controlled trial published in JAMA in 2008 (DeKosky et al., 2008).

GEM trial facts, from the published summary (DeKosky et al., 2008) and trade press report (GEM trial results, 2008)
People3,069 adults aged 75 and older
Ginkgo dose120 mg twice daily (240 mg a day) of extract
ComparisonPlacebo
LengthMedian 6.1 years
Dementia on ginkgo17.9%
Dementia on placebo16.1%
VerdictNo difference in dementia

Reading the result

What does 17.9% versus 16.1% actually mean?

It means ginkgo did not come out ahead. Scale it to 1,000 people: about 179 on ginkgo and 161 on placebo developed dementia (GEM trial results, 2008).

The researchers judged this gap as no real difference. It does not show that ginkgo causes dementia. It shows that six years of a standard dose gave no protection.

Why a big trial counts more

A trial with thousands of people over years is far harder to fool than a 30-person, 12-week study. Small studies can swing on a few lucky results.

All three herbs

How does ginkgo's evidence compare with bacopa and lion's mane?

Ginkgo sits near the bottom for the memory question, despite having the biggest trial. Size made the answer clear, and the answer was no.

  1. Bacopa
    Nine trials, 12+ weeks each

    Small gains in attention speed at 300-450 mg a day. (Kongkeaw et al., 2014)

  2. Lion's mane
    Small trials of 30-49 people

    Mixed results; gains faded after stopping in one trial. (LiverTox, Lion's mane)

  3. Ginkgo
    The GEM trial: 3,069 adults

    Did not prevent memory decline or dementia over about 6 years. (DeKosky et al., 2008)

  4. NeuroDyne
    Never studied as a product

    No trial of NeuroDyne, and no published amounts to compare. (FTC, Health claims)

The longer the bar, the more directly that evidence answers the question: will this bottle help my memory or focus? It sums up the linked sources in our own judgment; it is not a score from any study.

Bacopa has a small attention signal after 12 weeks; read how long bacopa takes. Lion's mane has three small, mixed trials.

Beyond GEM

What did the Cochrane review of 36 ginkgo trials find?

It found the evidence inconsistent and unreliable. Cochrane reviewers looked at 36 trials of ginkgo for cognitive impairment and dementia (Cochrane, Ginkgo 2009).

In plain terms, the trials did not agree, and their results could not be trusted to show a benefit. Side effects were no different from placebo.

The NCCIH digest for doctors adds that GEM did not lower dementia rates (NCCIH, Cognition digest). Two independent groups, one answer.

Try NeuroDyne with 60 days to decide1 fl oz dropper bottle · from $49 a bottle on 6 · free U.S. shipping on 3 or 6

Order now

Safety

Who should be careful with ginkgo?

Anyone on a blood thinner. NCCIH warns that ginkgo may raise bleeding risk with drugs such as warfarin (NCCIH, Ginkgo). Other reported side effects are dizziness, stomach upset and headache.

Think of a 66-year-old on warfarin whose daughter wants to buy her memory drops. Because NeuroDyne names ginkgo, the right first step is a call to her prescriber, with the bottle in hand.

Blood thinners, aspirin or surgery

Ask your doctor before taking NeuroDyne if you take a blood thinner or daily aspirin, or have surgery planned.

The full list is on our NeuroDyne side effects page, and our who it's for guide covers other groups.

The product

What does the GEM trial mean for NeuroDyne drops?

It means the "Enhances memory recall" line on the bottle is not backed by the biggest ginkgo study. GEM tested ginkgo alone at a known dose. NeuroDyne publishes no ginkgo amount at all.

GEM trial next to what is published for NeuroDyne (sales page and bottle images, October 11, 2026)
DetailGEM trialNeuroDyne
Ginkgo per day240 mgNot published
Other herbsNoneBacopa, lion's mane
FormSingle-ingredient extractLiquid drops, 30 mL a month
People studied3,0690
Brand graphic titled Inside NeuroDyne showing ginkgo, bacopa and lion's mane tiles
The brand graphic names ginkgo first among three herbs but gives no amounts, so no reader can compare it with the 240 mg GEM dose.

One fair point: ginkgo is among the most studied herbs, so its risks are well described. See the ginkgo ingredient profile.

Sources

Where do the GEM trial figures come from?

  1. Ginkgo biloba did not prevent dementia or Alzheimer disease in elderly people (GEM trial summary). Evidence-Based Nursing 12(2):56, summarizing JAMA 2008;300:2253, 2009.In GEM, 3,069 adults aged 75+ took 120 mg twice daily or a placebo for a median of 6.1 years. No difference in dementia.
  2. Ginkgo biloba has no benefits against dementia: Study. NutraIngredients (trade press, on the GEM trial), 2008.Of those on ginkgo, 17.9% developed dementia, against 16.1% on placebo.
  3. Ginkgo biloba for cognitive impairment and dementia. Birks J, Grimley Evans J. Cochrane Database of Systematic Reviews, 2009.36 trials. Any benefit was inconsistent and unreliable, and side effects matched placebo.
  4. Ginkgo: Usefulness and Safety. National Center for Complementary and Integrative Health, 2025.In large studies, ginkgo did not lower the risk of dementia. With blood thinners such as warfarin, it may raise bleeding risk. Reported side effects are dizziness, upset stomach and headache.
  5. Dietary Supplements and Cognitive Function, Dementia, and Alzheimer's Disease. National Center for Complementary and Integrative Health, 2022.Ginkgo did not lower dementia incidence in GEM; B vitamins showed no cognitive benefit in short trials.
  6. 7 Things To Know About Dietary Supplements for Cognitive Function. National Center for Complementary and Integrative Health, 2024.No conclusive evidence ginkgo slows cognitive decline. A supplement is no reason to put off seeing a provider about memory loss.
  7. Information for Consumers on Using Dietary Supplements. U.S. Food and Drug Administration, 2022.The FDA cannot approve supplements for safety and effectiveness before they go on sale. The FTC reviews supplement advertising.

FAQ

Ginkgo and the GEM trial: common questions

Does ginkgo biloba help memory in older adults?

Not in the largest trial. GEM gave 3,069 adults aged 75 and older ginkgo or placebo for a median 6.1 years, and dementia rates did not differ: 17.9% on ginkgo, 16.1% on placebo. A Cochrane review of 36 trials called the evidence inconsistent and unreliable.

What dose of ginkgo was used in the GEM trial?

Participants took 120 mg of ginkgo extract twice daily, or 240 mg a day, for a median 6.1 years. That is a standard research dose. NeuroDyne does not publish its ginkgo amount, so you cannot compare the drops with the GEM dose.

How much ginkgo is in NeuroDyne?

The amount is not published. Ginkgo is named in the sales FAQ and on the Inside NeuroDyne graphic, but no Supplement Facts panel appears on the sales page or in any bottle image. Ask the maker for the milligrams per serving.

Is ginkgo safe with warfarin or daily aspirin?

Ask your doctor first. NCCIH warns ginkgo may raise bleeding risk when combined with blood thinners such as warfarin. Because NeuroDyne names ginkgo, the same caution applies to the drops. Bring the bottle to your prescriber so they can read the label.

Should I stop ginkgo before surgery?

Tell your surgeon about it well before the date. Ginkgo may raise bleeding risk, so people with surgery planned should ask before taking any product that contains it, NeuroDyne included. Follow the timing your surgical team gives you.

Can ginkgo drops prevent Alzheimer's?

No study shows that. The GEM trial found ginkgo did not lower dementia or Alzheimer's rates over about 6 years. NeuroDyne is a dietary supplement, not a treatment for any disease. Memory loss that is new or getting worse needs a doctor's visit.

Why is ginkgo still sold for memory after the GEM trial?

FDA does not approve dietary supplements for safety or effectiveness before they are sold. Makers may use general memory wording if the label carries the standard not-evaluated statement. The bottle's claims are the maker's words, not a finding from GEM.

Is ginkgo biloba in NeuroDyne drops?

Yes. Ginkgo biloba is one of three herbs named in the NeuroDyne sales FAQ, with Bacopa monnieri and lion's mane. The amount of ginkgo is not published, so it cannot be compared with trial doses.

Does the GEM trial mean NeuroDyne will not help my memory?

Not exactly. The GEM trial tested ginkgo alone at 120 mg twice daily, not NeuroDyne. It shows ginkgo did not protect memory in that group, and no study of NeuroDyne exists to say more.

Who wrote this

Written and reviewed by

Written byThe NeuroDyne editorial teamNeurodynesupport, U.S. stocking partner for NeuroDyne

Plain-language pages built from the bottle images, the sales page and linked public health sources such as NIH, FDA and Cochrane.

Medically reviewed byDr. Kellyann Niotis, MD, PhysicianRole: Medical reviewerReview date: October 12, 2026

Page revised . Read our editorial standards and the way we check reviews. This website is run by Neurodynesupport, a U.S. stocking partner for NeuroDyne, not by the manufacturer. We are paid a commission when you buy through our order links.

U.S. stocking partner for NeuroDyne

Ready to try NeuroDyne?

Pick a pack. Check your bottle's directions first; each pack lasts through the full 60-day window.

  • Secure checkout
  • 60-day money-back window
  • Tracking in the order email
Two amber NeuroDyne dropper bottles with gold collars and navy labels: Cognitive Support Formula, improves focus, enhances memory recall, provides mental energy, 1 fl oz

NeuroDyne dropsFrom $49 a bottle · free U.S. shipping on 3+ · 60-day window

Order now